Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorota M Gertig

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Expert Review of Anti-Infective Therapy|August 9, 2011
Primary prophylactic human papillomavirus vaccination programs: future perspective on global impactJulia M L Brotherton, Dorota M Gertig
Statistics in Medicine|October 12, 2005
Forecasting age-specific breast cancer mortality using functional data modelsBircan Erbas, Rob J Hyndman, Dorota M Gertig
Australian and New Zealand Journal of Public Health|January 18, 2003
Public health aspects of genetic screening for hereditary haemochromatosis in AustraliaDorota M Gertig, Ashley Fletcher, John L Hopper
Mathematical Medicine and Biology : a Journal of the IMA|July 23, 2013
The time-evolution of DCIS size distributions with applications to breast cancer growth and progressionJames G Dowty, Graham B Byrnes, Dorota M Gertig
Sexual Health|May 20, 2011
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, AustraliaDorota M Gertig, Julia M L Brotherton, Marion Saville
The Medical Journal of Australia|April 19, 2012
Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, VictoriaBianca Barbaro, Julia M L Brotherton, Dorota M Gertig
The Medical Journal of Australia|November 12, 2003
Population genetic screening for hereditary haemochromatosisDorota M Gertig, John L Hopper, Katrina J Allen
Breast Cancer Research and Treatment|September 25, 2003
Duration of hormone replacement therapy, breast tumour size and grade in a screening programmeDorota M Gertig, Bircan Erbas, Ashley Fletcher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2004
Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?Bircan Erbas, Alison Amos, Ashley Fletcher, et al.
The Medical Journal of Australia|March 18, 2016
HPV vaccine impact in Australian women: ready for an HPV-based screening programJulia Ml Brotherton, Dorota M Gertig, Cathryn May, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Expert Review of Anti-Infective Therapy|August 9, 2011
Primary prophylactic human papillomavirus vaccination programs: future perspective on global impactJulia M L Brotherton, Dorota M Gertig
Statistics in Medicine|October 12, 2005
Forecasting age-specific breast cancer mortality using functional data modelsBircan Erbas, Rob J Hyndman, Dorota M Gertig
Australian and New Zealand Journal of Public Health|January 18, 2003
Public health aspects of genetic screening for hereditary haemochromatosis in AustraliaDorota M Gertig, Ashley Fletcher, John L Hopper
Mathematical Medicine and Biology : a Journal of the IMA|July 23, 2013
The time-evolution of DCIS size distributions with applications to breast cancer growth and progressionJames G Dowty, Graham B Byrnes, Dorota M Gertig
Sexual Health|May 20, 2011
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, AustraliaDorota M Gertig, Julia M L Brotherton, Marion Saville
The Medical Journal of Australia|April 19, 2012
Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, VictoriaBianca Barbaro, Julia M L Brotherton, Dorota M Gertig
The Medical Journal of Australia|November 12, 2003
Population genetic screening for hereditary haemochromatosisDorota M Gertig, John L Hopper, Katrina J Allen
Breast Cancer Research and Treatment|September 25, 2003
Duration of hormone replacement therapy, breast tumour size and grade in a screening programmeDorota M Gertig, Bircan Erbas, Ashley Fletcher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2004
Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?Bircan Erbas, Alison Amos, Ashley Fletcher, et al.
The Medical Journal of Australia|March 18, 2016
HPV vaccine impact in Australian women: ready for an HPV-based screening programJulia Ml Brotherton, Dorota M Gertig, Cathryn May, et al.
Pageof 6